Form 4: Xylem Inc. Executive Geri-Michelle McShane Reports Stock Transactions
SEC Form 4
Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., reports acquisition and disposal of common stock related to vesting of performance-based stock units and tax liability coverage.
Summary
- On March 1, 2025, Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., reported transactions involving Xylem's common stock.
- McShane acquired 526 shares at $129.78 each upon vesting of performance-based stock units related to Total Shareholder Return.
- She also acquired 630 shares at $129.78 each upon vesting of performance-based stock units related to ROIC.
- An additional 630 shares were acquired at $129.78 each upon vesting of performance-based stock units related to Revenue.
- 687 shares were disposed of at $129.78 each to cover tax liabilities related to the vesting of performance-based stock units.
- 236 shares were disposed of at $129.78 each to cover tax liabilities related to the vesting of restricted stock units granted on March 1, 2022 (87), March 1, 2023 (82), and March 1, 2024 (67).
- Following these transactions, McShane beneficially owns 4,656 shares of Xylem Inc. common stock directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports stock transactions by an executive, which are related to pre-existing compensation plans and performance metrics. There is no indication of positive or negative sentiment.
Positives
- The vesting of performance-based stock units indicates that the company has met certain performance criteria related to Total Shareholder Return, ROIC, and Revenue.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with the most knowledge of the company's performance.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting of performance-based stock units tied to metrics like Total Shareholder Return and ROIC is a common practice among publicly traded companies.
- Companies like Danaher, Agilent, and Thermo Fisher Scientific also use similar incentive plans to reward executives for achieving specific financial and strategic goals.
Stakeholder Impact
- The vesting of stock units and subsequent sale of shares to cover tax liabilities may have a minor impact on the stock price.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date of Amended and Restated Xylem Omnibus Incentive Plan |
| 2022-03-01 | Grant date of performance-based stock units and restricted stock units |
| 2023-03-01 | Grant date of restricted stock units |
| 2024-03-01 | Grant date of restricted stock units |
| 2025-03-01 | Transaction date for stock acquisitions and disposals |
| 2025-03-04 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.